FDA Approves B+L and Clearside Biomedical Drug for Treatment of Macular Edema Associated With Uveitis

By Staff
Tuesday, October 26, 2021 1:46 PM LAVAL, QC and ALPHARETTA, Ga.—Bausch + Lomb, a global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) and Clearside Biomedical, Inc. (Nasdaq: CLSD) announced Monday that the U.S. Food and Drug Administration (FDA) has approved the drug Xipere (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis, a form of eye inflammation. "With this FDA approval, Xipere is the first and only therapy available in the United States that utilizes the suprachoroidal space to treat patients suffering from macular edema associated with uveitis, which is the leading cause of vision loss in people with uveitis," said Joseph C. Papa, chairman and CEO, Bausch Health. Read More

20/20 Magazine: Material Eyes

By Staff
Tuesday, October 26, 2021 1:29 PM With so many styles, shapes and colors available in eyewear, sometimes it’s easy to overlook the details that make up the frame’s foundation, such as its materials. This month, 20/20 digs into the composition of a frame’s anatomy and how it ranks among independent eyecare professionals with our Materials MarketPulse Survey conducted by Jobson Optical Research. The study surveyed 318 qualified respondents at independent optical locations in August 2021. Read More

CooperVision’s Michele Andrews Talks About the Evolution of the ‘Best Practices’ Recognition Program

By Staff
Monday, October 25, 2021 2:21 PM NEW YORK—CooperVision opened the application process for its Best Practices program in mid-September, and in doing so provided some updates that are designed to make it easier for eyecare practices to enter the program and for the judges to evaluate the diverse group of entries and focus areas the competition has come to attract. With the changes, in 2022 Best Practices will be recognized specifically for the areas of optometry in which they truly shine, CooperVision noted. VMAIL Weekend recently sat down with Michele Andrews, OD, CooperVision’s vice president, professional & government affairs, to get a better understanding of what’s new in the Best Practices program. Read More

Review of Ophthalmology: First Ranibizumab Biosimilar Approved

By Staff
Monday, October 25, 2021 2:13 PM It was no surprise to those who follow industry and regulatory developments affecting the retina specialty. On September 17, 2021, the U.S. Food and Drug Administration announced the approval of the first ophthalmology biosimilar to ranibizumab (Lucentis, Genentech/Roche), the anti-vascular endothelial growth factor agent Byooviz. But as more biosimilar approvals seem imminent as patents expire, some wonder how this regulatory approach translates to ophthalmology and what impact it could have on community practices and patients downstream. Read More

VM Summit Session Examines How to Rebuild Patient Trust in the Wake of the Pandemic

By Staff
Friday, October 22, 2021 2:30 PM NEW YORK—As the Oct. 20 virtual VM Leadership Summit kicked off on Wednesday afternoon, two expert speakers talked about how the pandemic has put patients' trust to the test, and more importantly, how providers can tackle the issue of misinformation and help counter the formidable challenge of rebuilding that trust. In a session titled Rebuilding Trust, Dr. John Whyte, chief medical officer for WebMD and Jennifer Hauser, head of Edelman’s Wellness 360 business unit, shared views about how today’s eyecare professionals can build trust with their patients. Read More

Review of Myopia Management: Parents Increasingly Seek Myopia Management, Says GMAC’s Two-Year Study

By Staff
Friday, October 22, 2021 2:26 PM The Global Myopia Awareness Coalition (GMAC) conducted a study between 2019 and 2021 to get a better idea of parents’ awareness and perceptions about myopia. The organization analyzed two main sources of data: an online survey that was sent to parents of children under 18 years old, and Google trends that tracked the ongoing searches related to myopia. Now, GMAC has released the results from this two-year study, and there were several key takeaways. Read More

Retina Consultants of America Announces Addition of Colorado Retina Associates

By Staff
Thursday, October 21, 2021 2:14 PM SOUTHLAKE, Texas—Retina Consultants of America (RCA), a comprehensive physician management services organization, has added Colorado Retina Associates (CRA) to its national consortium. With the addition of Colorado Retina, RCA adds a key partner in the Rocky Mountain Region and expands its footprint into a new territory, according to an announcement Wednesday.  CRA was founded in 2006 through the merger of three independent practices and has grown to include 13 board-certified and fellowship-trained ophthalmologists in the greater Denver-Boulder metropolitan area. Read More

20/20 Europe: Hoya Vision Care—Certified ECP Training Courses Part of Shared Global Mission to Address Myopia in Children

By Staff
Thursday, October 21, 2021 2:02 PM This summer, Hoya Vision Care announced the rollout of a suite of co-created certified training courses to educate, inform and empower eyecare professionals (ECPs) to prescribe spectacle lenses for children in the global fight to address and manage myopia. The bespoke program developed together includes certified courses on general knowledge about myopia, the myopia management landscape and training on the MiYOSMART spectacle lens. The content is housed on Hoya’s global training platform, available in more than 20 countries. Read More

ECPs Are Hopeful About Business This Month, But Staffing Challenges Lead Their Concerns, Per Wave 27 of Jobson Research's Latest ECP Coronavirus Survey

By Staff
Wednesday, October 20, 2021 12:54 PM NEW YORK—Staffing challenges seem to be the biggest concern facing eyecare professionals and optical retailers now, with some 38 percent of those surveyed in late September pointing out that a "lack of staff" is the number one reason they will have trouble serving more patients going forward, more than issues such as a lack of patient traffic or government restrictions on business due to COVID-19. Nevertheless,  62 percent believe that their practice does have the capability to serve more patients now among those taking part in Wave 27 of Jobson Research's latest Coronavirus Survey, which was conducted Sept. 27-30. Read More

Review of Optometry: Major Eye Disorders Represent Growing Burden on Medicare

By Staff
Wednesday, October 20, 2021 12:47 PM The latest report on the impact of age-related eye diseases (AMD, glaucoma, cataract and diabetic retinopathy) on the Medicare burden says that a significant portion of patients are affected by these diseases and that related spending accounts for approximately 4.3 percent of Medicare Part B and 1 percent of Medicare Part D spending. Overall, vision loss and eye disorders cost an estimated $139 billion in 2013. More than 40 percent of the enrolled population is affected by ocular conditions and the numbers are increasing. Read More

Halloween: A History

By Staff
Tuesday, October 19, 2021 2:33 PM NEW YORK—Earlier this week, Dr. Fauci told CNN’s State of the Union that he thinks Halloween 2021 is a go. “I think that, particularly if you're vaccinated, you can get out there and enjoy it,” he said, referring to trick-or-treating for kids, and Halloween parties for adults. Last year, Halloween celebrations were muted, with fewer parties and fewer trick-or-treaters all around—and while there’s nothing wrong with a cozy, spooky Halloween at home celebrated with a scary movie marathon, there’s something special about knowing we can get back out there this year and spread the Halloween joy. Read More

Review of Optometric Business: Building a Sports Vision Niche Worth $184,000+ Annually in Net Profit

By Staff
Tuesday, October 19, 2021 2:26 PM Sports eyewear provides a great service to patients, protecting their eyes, while helping to enhance performance. Sales of sports eyewear in my practice generate around $170,000 annually, and sales of sports eye vitamins generate $14,000 annually. Here is how I am building a sports vision niche that enables my patients to get more out of the sports they participate in while helping my practice to generate significant profitability. Read More

Cast Your Votes for Jobson's 2021 EyeVote Readers' Choice Awards

By Staff
Monday, October 18, 2021 2:18 PM NEW YORK—Vision Monday and 20/20 Magazine are hosting the 13th annual EyeVote Readers' Choice Awards to identify the optical industry’s favorite products and companies this year. These two Jobson Medical Information publications are teaming up once again this fall to get readers’ opinions by asking optical retailers’ and ECPs to identify their favorite products in 20 distinct categories: optical frames, spectacle lenses, sunglasses, Rx sun lenses, contact lenses, optical equipment for wholesale prescription labs, optical supplies, ECP/retail in-office lab equipment, diagnostic instruments, practice management software, EHR software, online ordering website, patient engagement systems, dispensing/measuring fitting systems, online and social media marketing services, PPE, contactless dispensing devices, virtual try-on tools, telehealth solution and Social Purpose missions. Read More

Women In Optometry: Medication Information at Your Fingertips

By Staff
Monday, October 18, 2021 2:07 PM When Megan Taylor, OD, FAAO, was a clinical assistant professor at The Ohio State University College of Optometry, a colleague mentioned that he had been working on a project with EyeMedsNow, and the group was looking for some help with the website. “I was still fresh out of my residency; ocular disease was my passion. Once I found out what the website was hoping to become, I was very interested,” she says. EyeMedsNow is a software platform designed to streamline informed decision-making at the point of care by allowing eyecare professionals and their staff to access concise medication information for any drug prescribed for eye conditions. Read More

World Sight Day Festivities Raise Dollars, Commitments to Eye Tests and Advocacy for Raising Awareness for Eyecare Access as UN Diplomats Mark World Sight Day

By Staff
Friday, October 15, 2021 9:03 AM NEW YORK—In events and communications that spanned the world, World Sight Day 2021, Oct. 14, enabled many eyecare professionals, companies, NGOs and volunteer organizations to contribute to a crescendo of messaging about the importance of preserving sight with annual sight tests and advancing the need to provide access to more than one billion people around the world suffering from preventable vision loss. To mark the day, key United Nations (UN) diplomats joined together with the International Agency for the Prevention of Blindness and Global World Sight Day partner OneSight, for a special sight screening. Read More